Articles

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

Banach M, Surma S, Toth PP; endorsed by the International Lipid Expert Panel (ILEP)

First published: November 2, 2023  DOI: 10.5114/aoms/174743